The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...

Carbon Core EMS ab stimulator 2026 availability: multi-zone belt, arm, and leg strap training system now offered ...

Yale researchers have previously shown that people who undergo moderate calorie restriction—a 14% reduction in calorie intake ...

Doctors say a literal stress vaccine does not exist yet, but research is exploring ways to train the body’s stress response ...

Across a number of studies, researchers have found that following a Mediterranean-style diet—which includes olive oil and ...

Nexxen, the advertising technology platform powered by unique data and media, today announced that H/L, a renowned multiservice and independent agency, is the first to programmatically activate native ...

Panakeia (“the Company”), the world’s first in silico multi-omics company, today unveiled landmark pathway activation data in cancers at the American Association for Cancer Research (AACR) Annual ...

Positive high-level results from a prespecified interim analysis of the I CAN Phase III trial showed that Ultomiris (ravulizumab) met its primary ...

NIQ's relationship with Stirista aligns purchase-based intelligence with data-driven activation capabilities for advertising planning and activation.

Already approved to treat four rare diseases, AstraZeneca’s Ultomiris has shown its ability against another rare disorder, ...

You finally took the plunge and started taking a GLP-1 drug to improve your health. You’re keeping up with your GLP-1 pill or ...

Should you take vitamin D with magnesium and vitamin K2? Here’s how these supplements work together, plus safety tips and ...